Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07278310 · ClinicalTrials.gov registry record · NA
STAR Trial (Siegel Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis)
A NA study, sponsored by MiRus.
- Recruiting
- Registry status
- NA
- Development phase
- 1,025
- Enrollment target
NCT07278310 is a NA study that is actively recruiting participants, run by MiRus. The registered enrollment target is 1,025 participants.
The verdict
NCT07278310, a NA study, is actively recruiting participants, sponsored by MiRus.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,025 participants
- Enrollment target
Study Summary
To evaluate the safety and efficacy of Siegel™ TAVR System in the treatment of subjects with symptomatic severe native aortic stenosis.
Interventions
- DEVICE TAVR Device
- DEVICE Siegel TAVR Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,025 participants |
| Start Date | 2026-04 |
| Est. Completion | 2028-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07278310
The ClinicalTrials.gov registry entry for NCT07278310 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,025 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MiRus, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which TAVR Device is the first listed.
NCT07278310 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07278310 about?
NCT07278310 is a clinical study titled "STAR Trial (Siegel Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis)". To evaluate the safety and efficacy of Siegel™ TAVR System in the treatment of subjects with symptomatic severe native aortic stenosis.
What is the current status of trial NCT07278310?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,025 participants. The study started on 2026-04. Estimated completion is 2028-04.
What interventions are being tested in trial NCT07278310?
The interventions under investigation include: TAVR Device (DEVICE), Siegel TAVR Device (DEVICE).
Who is sponsoring clinical trial NCT07278310?
This trial is sponsored by MiRus, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.